{
  "content": ". Am Heart J. 2015, 170:1033-1041.e1. 10.1016/j.ahj.2015.07.023 36. Zaki HA, Shaban E, Bashir K, Iftikhar H, Zahran A, Salem W, Elmoheen A: A comparative study between amiodarone and implantable cardioverter-defibrillator in decreasing mortality from sudden cardiac death in high-risk patients: a systematic review and meta-analysis. Cureus. 2022, 14:e26017. 10.7759/cureus.26017 37. Chiang JY, Chen PC, Yang YH, et al.: Digoxin-amiodarone Combination is associated with excess all-cause mortality in patients with atrial fibrillation. Sci Rep. 2020, 10:4101. 10.1038/s41598-020-61065-4 38. Wyse DG: Overview of endpoints in atrial fibrillation studies . Heart Rhythm. 2004, 1:B3-7.",
  "source": "https://pdfs.semanticscholar.org/ff77/522d79d731c5b00db94e402132f7770745ac.pdf",
  "chunk_id": "1a5cdfeb-5b13-4de7-b8f6-2c48aaa8828c",
  "similarity_score": 0.35277676582336426,
  "query": "atrial fibrillation mortality outcomes cardiovascular events stroke prevention amiodarone beta-blockers hazard ratio",
  "rank": 5,
  "title": "An Integrative Comparative Study Between Digoxin and Amiodarone as an Emergency Treatment for Patients With Atrial Fibrillation With Evidence of Heart Failure: A Systematic Review and Meta-Analysis",
  "authors": "Hany A. Zaki, Khalid Bashir, Haris Iftikhar, Waleed Salem, Eslam Hussein Mohamed, Helmy M. Elhag, Mohamed Hendy, Ahmed Abdu O. Kassem, Emad El-Din Salem, Amr Elmoheen",
  "year": "2022",
  "journal": "Cureus",
  "reference": "Zaki, H. A., Bashir, K., Iftikhar, H., Salem, W., Mohamed, E. H., Elhag, H. M., Hendy, M., Kassem, A. A. O., Salem, E. E.-D., & Elmoheen, A. (2022). An integrative comparative study between digoxin and amiodarone as an emergency treatment for patients with atrial fibrillation with evidence of heart failure: A systematic review and meta-analysis. Cureus, 14(7), e26800. https://doi.org/10.7759/cureus.26800",
  "doi": "10.7759/cureus.26800",
  "chunk_index": 82,
  "total_chunks": 84,
  "retrieved_at": "2025-07-24T21:57:59.084506"
}